Articles

The Fascinating History of the Color Red

  • by

The Fascinating History of the Color Red The color red was most likely the first color (besides black and white) to be registered in our ancient ancestors brains. The Doctor Weighs In

Michigan expands antibody treatment to cut hospitalizations

  • by

The drugs, delivered intravenously and made by Regeneron Pharmaceuticals and Eli Lily, have concentrated doses of lab-made antibodies to fight COVID-19 and are geared toward people who are at high risk for severe symptoms or having to be hospitalized.

J&J vaccine to remain in limbo while officials seek evidence

  • by

At an emergency meeting, advisers to the Centers for Disease Control and Prevention wrestled with the fact that the U.S. has enough alternative shots to vaccinate its population but other countries anxiously awaiting the one-and-done vaccine may not.

Anthem, K Health, Blackstone launch digital health company

  • by

The new joint venture will bring K Health’s artificial intelligence-driven technology to the consumer, employer and insurer markets. The solution enables patients to understand their symptoms and connect with a doctor if needed.

Medtronic Launches World’s First 7-Day Wear Infusion Set to Reduce Burden for People with Diabetes

  • by

What You Should Know: – Medtronic has announced the launch of the world’s first and only infusion set that can be worn for up to seven days (instead of the typical three) in select European countries. The infusion set is responsible for delivering insulin from… Read More »Medtronic Launches World’s First 7-Day Wear Infusion Set to Reduce Burden for People with Diabetes

Public health, racial equity, climate action drive Biden’s budget requests for healthcare

  • by

President Joe Biden has submitted his discretionary budget for 2022 to Congress. Among its healthcare provisions are funding requests for the CDC, mental health and social determinants of health programs. But there are some unusual requests as well, such as funding for an Office of… Read More »Public health, racial equity, climate action drive Biden’s budget requests for healthcare

CMS issues new guidance to enforce price transparency rule

  • by

CMS issued new guidance on Github for “developers and consumers of the machine-readable files required through the Transparency in Coverage rule” after an investigation into hospital pricing websites revealed hundreds were using code to block information from showing up on search engines.

In MedCity Pivot podcast, Glen Tullman says other care navigation firms aren’t really taking risks

  • by

Livongo’s founder has created a new care navigation venture because he believes that both the experience that people undergo as they look for care and the level of risk that vendors are willing to take when they work with self-insured employers leave much to be… Read More »In MedCity Pivot podcast, Glen Tullman says other care navigation firms aren’t really taking risks

Cleveland Clinic researchers measure pandemic’s effect on Medicare population

  • by

Research conducted by the Cleveland Clinic and Massachusetts-based startup Health Data Analytics Institute (HDAI) measured the difference in mortality during the pandemic  between people covered by Medicare in long-term care facilities and in the community. While a Covid-19 diagnosis increased deaths in both settings, there… Read More »Cleveland Clinic researchers measure pandemic’s effect on Medicare population

Surgeon General’s son interrupts morning TV interview

  • by

Surgeon General Vivek Murthy’s son made an appearance during a Wednesday morning interview in which Murthy was discussing the nation’s pause on the Johnson & Johnson coronavirus vaccine.As Murthy was answering questions from Gayle King on “…

1 in 5 still say they won’t get COVID-19 vaccine: poll

  • by

About one in five U.S. adults say they will not get a vaccine to protect against the coronavirus, according to a poll released Wednesday by Monmouth University.Twenty-one percent of adults surveyed said they will not get a shot, a marginal drop from…

Mayo Clinic launches two tech companies

  • by

One of the companies, Anumana, is seeking clearance from the Food and Drug Administration to market an artificial-intelligence tool to detect heart conditions.

Putin gets second dose of Russian vaccine: report

  • by

Russian President Vladimir Putin has received the second dose of a Russian coronavirus vaccine, Reuters reported on Tuesday, citing the Interfax news agency.Putin received his first inoculation last month, but refused to disclose which vaccine he…

Most differences in DNA binding compounds found at birth in children conceived by IVF not seen in early childhood

  • by

Compared to newborns conceived traditionally, newborns conceived through in vitro fertilization (IVF) are more likely to have certain chemical modifications to their DNA, according to a new study. The changes involve DNA methylation — the binding of compounds known as methyl groups to DNA —… Read More »Most differences in DNA binding compounds found at birth in children conceived by IVF not seen in early childhood

PhRMA member companies share how they are improving clinical trial diversity

  • by

As part of the biopharmaceutical industry’s efforts to improve health outcomes for patients in underserved communities, PhRMA member companies are identifying ways to improve clinical trial diversity and reduce barriers to participation for Black and Brown communities. As these efforts continue to take shape, our… Read More »PhRMA member companies share how they are improving clinical trial diversity

Merck KGaA Expand its Collaboration with NKMax to Evaluate the Combination of SNK01 + Erbitux (cetuximab) for Metastatic NSCLC

  • by

Shots: The companies plan to conduct a P-I/IIa trial assessing the safety and anti-tumor activity of SNK01 + gemcitabine/carboplatin or gemcitabine/carboplatin + Erbitux (cetuximab) in patients with LA or mNSCLC after prior TKI therapy NKMax will sponsor the study while Merck KGaA will supply cetuximab… Read More »Merck KGaA Expand its Collaboration with NKMax to Evaluate the Combination of SNK01 + Erbitux (cetuximab) for Metastatic NSCLC

Innovent and Lilly Present Results of Tyvyt (sintilimab) in P-III ORIENT-3 Trial as 2L Treatment for Advanced or Metastatic Squamous NSCLC at AACR 2021

  • by

Shots: The P-III ORIENT-3 trial involves assessing the efficacy and safety of Tyvyt (sintilimab) vs docetaxel (q3w) in 290 patients in a ratio (1:1) as a 2L treatment for advanced or m-sqNSCLC The trial met its 1EP i.e improvement in OS, mOS (11.79 vs 8.25… Read More »Innovent and Lilly Present Results of Tyvyt (sintilimab) in P-III ORIENT-3 Trial as 2L Treatment for Advanced or Metastatic Squamous NSCLC at AACR 2021

Gilead’s Trodelvy approved in metastatic urothelial cancer

  • by

Gilead’s Trodelvy has another string to its bow after FDA approval in patients with advanced metastatic urothelial cancer.  Trodelvy (sacituzumab govitecan) has been approved for locally advanced or metastatic urothelial cancer, following a platinum-containing chemotherapy and PD-1/PD-L1 inhibitor immunotherapy. The US pharma hopes that the… Read More »Gilead’s Trodelvy approved in metastatic urothelial cancer

The Memo: Specter of vaccine hesitancy rises after J&J blow

  • by

The pause in the use of the Johnson & Johnson COVID-19 vaccine announced Tuesday is virtually certain to exacerbate vaccine hesitancy, dealing a fresh blow to the nation’s efforts to recover from the pandemic.Vaccine hesitancy is on its way to…

A Year Into Pandemic, Federal Officials Design New Mask Guidelines to Better Protect More Workers

  • by

Federal officials announced new measures to help get fresh, new N95 masks to health care workers and expand their use in other industries after scientists argued that the highly protective masks are essential to keep workers safe from covid-19. Use Our Content It can be… Read More »A Year Into Pandemic, Federal Officials Design New Mask Guidelines to Better Protect More Workers

AstraZeneca’s Tagrisso (osimertinib) Receives the NMPA’s Approval for the Adjuvant Treatment of Patients with Early-Stage EGFR-Mutated Lung Cancer

  • by

Shots: The approval is based on results from the P-III ADAURA trial assessing Tagrisso (80mg, qd) vs PBO in 682 patients with stage IB, II, IIIA EGFRm NSCLC following complete tumor resection and adjuvant chemotherapy as indicated for three years or until disease recurrence Results:… Read More »AstraZeneca’s Tagrisso (osimertinib) Receives the NMPA’s Approval for the Adjuvant Treatment of Patients with Early-Stage EGFR-Mutated Lung Cancer

Vaccine rollout hits a snag

  • by

A pause in administration of the Johnson & Johnson COVID-19 vaccine is dealing a blow to U.S. vaccination efforts that have largely been speeding along.The announcement from federal health officials on Tuesday morning, prompted by extremely rare…

House passes bill to avert Medicare cuts

  • by

The House on Tuesday approved a bill that would put off automatic cuts to Medicare provider payments until the end of the year.The bill passed with a strong bipartisan majority of 384-38.Technically, the House vote comes nearly two weeks after the…

Long-Term Care Expert David Grabowski: Home-Based Care Versus Nursing Homes Is a ‘False Dichotomy’

  • by

Long-term care providers have always had to stay on top of ever-changing shifts in trends, policies and regulations. The COVID-19 emergency has only made this task even more important. In today’s fast-paced environment, Harvard Medical School professor David Grabowski has turned into a major voice.… Read More »Long-Term Care Expert David Grabowski: Home-Based Care Versus Nursing Homes Is a ‘False Dichotomy’

Five questions raised by the Johnson & Johnson vaccine pause

  • by

The U.S. health agencies’ decision to recommend a pause in administering the Johnson & Johnson vaccine nationwide stirred up confusion on Tuesday, leaving many with questions.The Food and Drug Administration (FDA) and the Centers for Disease…

Stocks close mixed as regulators seek pause in J&J vaccine

  • by

Dow component Johnson & Johnson fell 1.5% after U.S. regulators recommended a pause in using its single-dose COVID-19 vaccine to investigate reports of possibly dangerous blood clots. Moderna, which also makes a COVID-19 vaccine, rose 6.8%.

Biden says vaccine supply not impacted by J&J pause

  • by

President Biden on Tuesday maintained that the decision to pause the administration of Johnson & Johnson’s coronavirus vaccine will not impact the country’s vaccine supply.”My message to the American people on the vaccine is, I told y’all I…

Cohere Health Raises $36M to Automate Prior Authorization Between Payers & Providers

  • by

What You Should Know: – Boston-based health IT company Cohere Health has closed a $36 million Series B funding round led by Polaris Partners, with additional participation from new investors Longitude Capital and Deerfield Management, as well as existing investors Flare Capital Partners and Define Ventures. The round comes less than a… Read More »Cohere Health Raises $36M to Automate Prior Authorization Between Payers & Providers

‘We’re Essentially Moving Toward Value-Based Care’: Companionship Startup Papa Raises $60M

  • by

Within the past year, in-home companionship startup Papa has set up shop in all 50 states, launched a new virtual health offering and expanded its relationships with payer partners. Papa is in the spotlight once again, with its latest announcement being a $60 million Series… Read More »‘We’re Essentially Moving Toward Value-Based Care’: Companionship Startup Papa Raises $60M

White House seeks to reassure after J&J vaccine pause

  • by

The White House on Tuesday sought to reassure the public after health officials called for a pause on the use of the Johnson & Johnson COVID-19 vaccine because of rare cases of blood clots in vaccinated people.Anthony Fauci, the government’s top…

U.S. Halts Johnson and Johnson Vaccine

  • by

Federal health agencies made the decision to halt the use of the Johnson and Johnson vaccine after six women between the ages of 18 and 48 experienced blood clots within one to three weeks of vaccination.

EU seeking ‘urgent clarification’ on Johnson & Johnson Covid vaccine delay

  • by

Company has said it is postponing deployment in Europe following concerns about blood clots in US Coronavirus – latest updates See all our coronavirus coverage The European commission is seeking “urgent clarification” from Johnson & Johnson after the company’s “completely unexpected” announcement that it has… Read More »EU seeking ‘urgent clarification’ on Johnson & Johnson Covid vaccine delay